SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 03, 09:59
4245.40
42.8 (1.02%)
VOLUME 1,611
LIVE
NSE
Sep 03, 09:59
4249.00
48.85 (1.16%)
VOLUME 31,615
Earnings News on Dr Reddys Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Buy Dr Reddys at every dip; cautious on Cipla: IIFL 

11.11 am | 31 Jul 2015 |  Source: CNBC-TV18

Given the numbers and the valuations the brokerage house would refrain from hiking the target price for Cipla from the current Rs 1070, Bhavesh Gandhi...

Business mix change drove gross margins higher: Dr Reddy's 

8.22 pm | 30 Jul 2015 |  Source: CNBC-TV18

In an interview with CNBC-TV18's Archana Shukla and Nayantara Rai, Saumen Chakraborty, India - President, CFO and Global IT Head, Dr Reddy's Laborator...

Dr Reddy's Q1 net up 14% at Rs 626 cr led by US & India biz 

2.21 pm | 30 Jul 2015 |  Source: Moneycontrol.com

Total income, during the quarter, rose to Rs 3,758 crore up 7 percent from Rs 3,517.5 crore year-on-year. It earned forex gain of Rs 1.2 crore in Q1F...

Dr Reddy's Labs Q1 PAT seen up 6.2% at Rs 584.3 cr: MOST

9.15 am | 30 Jul 2015 |  Source: Moneycontrol.com

Sales are expected to decrease by 0.8 percent Q-o-Q (up 9.2 percent Y-o-Y) to Rs 3840.1 crore, according to Motilal Oswal....

Dr Reddy's Labs Q1 net seen up 4%, US biz may grow 10-12% 

11.59 am | 29 Jul 2015 |  Source: CNBC-TV18

Revenue is seen rising 9.1 percent to Rs 3,837.21 crore from Rs 3,517.5 crore during the same period....

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.